BRISTOL-MYERS SQUIBB CO (BMY) Fundamental Analysis & Valuation
NYSE:BMY • US1101221083
Current stock price
59.43 USD
+0.49 (+0.83%)
At close:
59.33 USD
-0.1 (-0.17%)
After Hours:
This BMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BMY Profitability Analysis
1.1 Basic Checks
- In the past year BMY was profitable.
- BMY had a positive operating cash flow in the past year.
- Of the past 5 years BMY 4 years were profitable.
- Each year in the past 5 years BMY had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 7.83%, BMY belongs to the best of the industry, outperforming 88.60% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 38.19%, BMY belongs to the top of the industry, outperforming 96.89% of the companies in the same industry.
- BMY's Return On Invested Capital of 19.52% is amongst the best of the industry. BMY outperforms 95.85% of its industry peers.
- BMY had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 13.06%.
- The 3 year average ROIC (14.47%) for BMY is below the current ROIC(19.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- With an excellent Profit Margin value of 14.64%, BMY belongs to the best of the industry, outperforming 88.08% of the companies in the same industry.
- In the last couple of years the Profit Margin of BMY has grown nicely.
- BMY has a better Operating Margin (35.82%) than 96.37% of its industry peers.
- In the last couple of years the Operating Margin of BMY has grown nicely.
- BMY has a Gross Margin of 72.63%. This is amongst the best in the industry. BMY outperforms 80.83% of its industry peers.
- In the last couple of years the Gross Margin of BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. BMY Health Analysis
2.1 Basic Checks
- BMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, BMY has more shares outstanding
- Compared to 5 years ago, BMY has less shares outstanding
- Compared to 1 year ago, BMY has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.52 indicates that BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.52, BMY is doing good in the industry, outperforming 66.32% of the companies in the same industry.
- BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as BMY would need 3.51 years to pay back of all of its debts.
- BMY has a Debt to FCF ratio of 3.51. This is amongst the best in the industry. BMY outperforms 89.12% of its industry peers.
- A Debt/Equity ratio of 2.33 is on the high side and indicates that BMY has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 2.33, BMY is doing worse than 78.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.52 |
ROIC/WACC2.22
WACC8.81%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that BMY should not have too much problems paying its short term obligations.
- The Current ratio of BMY (1.26) is worse than 76.17% of its industry peers.
- A Quick Ratio of 1.14 indicates that BMY should not have too much problems paying its short term obligations.
- BMY has a Quick ratio of 1.14. This is in the lower half of the industry: BMY underperforms 73.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. BMY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- The Earnings Per Share has been decreasing by -0.92% on average over the past years.
- The Revenue has decreased by -0.22% in the past year.
- The Revenue has been growing slightly by 2.54% on average over the past years.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- BMY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.15% yearly.
- The Revenue is expected to decrease by -5.54% on average over the next years.
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue Next Year-1.85%
Revenue Next 2Y-1.95%
Revenue Next 3Y-5.42%
Revenue Next 5Y-5.54%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. BMY Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 9.66, the valuation of BMY can be described as reasonable.
- Based on the Price/Earnings ratio, BMY is valued cheaply inside the industry as 91.71% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 25.61, BMY is valued rather cheaply.
- BMY is valuated reasonably with a Price/Forward Earnings ratio of 9.38.
- BMY's Price/Forward Earnings ratio is rather cheap when compared to the industry. BMY is cheaper than 88.60% of the companies in the same industry.
- BMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.79, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.66 | ||
| Fwd PE | 9.38 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BMY is valued cheaply inside the industry as 93.26% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 91.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.42 | ||
| EV/EBITDA | 7.23 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BMY does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of BMY may justify a higher PE ratio.
- BMY's earnings are expected to decrease with -4.05% in the coming years. This may justify a cheaper valuation.
PEG (NY)3.25
PEG (5Y)N/A
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
5. BMY Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 4.34%, BMY is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.79, BMY pays a better dividend. On top of this BMY pays more dividend than 96.37% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.34% |
5.2 History
- On average, the dividend of BMY grows each year by 6.51%, which is quite nice.
- BMY has been paying a dividend for at least 10 years, so it has a reliable track record.
- BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.51%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- BMY pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
- BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
BMY Fundamentals: All Metrics, Ratios and Statistics
59.43
+0.49 (+0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners83.3%
Inst Owner Change1.17%
Ins Owners0.02%
Ins Owner Change2.88%
Market Cap121.03B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target62.03 (4.37%)
Short Float %1.65%
Short Ratio2.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.34% |
Yearly Dividend2.51
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years3
Div Non Decr Years3
Ex-Date04-02 2026-04-02 (0.63)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)6.85%
PT rev (3m)15.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.97%
EPS NY rev (1m)4.07%
EPS NY rev (3m)3.91%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)1.92%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)6.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.66 | ||
| Fwd PE | 9.38 | ||
| P/S | 2.51 | ||
| P/FCF | 9.42 | ||
| P/OCF | 8.55 | ||
| P/B | 6.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.23 |
EPS(TTM)6.15
EY10.35%
EPS(NY)6.33
Fwd EY10.66%
FCF(TTM)6.31
FCFY10.61%
OCF(TTM)6.95
OCFY11.7%
SpS23.67
BVpS9.07
TBVpS-10.99
PEG (NY)3.25
PEG (5Y)N/A
Graham Number35.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.52 |
F-Score7
WACC8.81%
ROIC/WACC2.22
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.85%
Revenue Next 2Y-1.95%
Revenue Next 3Y-5.42%
Revenue Next 5Y-5.54%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.47%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / BMY Fundamental Analysis FAQ
What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BMY.
What is the valuation status for BMY stock?
ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.
What is the profitability of BMY stock?
BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 9 / 10.
Can you provide the financial health for BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (BMY) is 5 / 10.
What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BMY) stock?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to grow by 2.98% in the next year.